WARNING: This is a development version of myUMBC. All content should be considered for testing purposes only and could be changed or deleted at any time.
UMBC research team develops statistical analysis to enable targeted cancer drug development
UMBC News·April 20, 2017 at 5:06 PM
The new method is “a really good way to identify important variants that you wouldn’t normally find in traditional methods,” says Thomas Peterson Ph.D. '16, who conducted this work as a student in the lab of UMBC biologist Maricel Kann.